Genomma Lab Internacional (GNMLF) Expected to Release Quarterly Earnings on Wednesday

Genomma Lab Internacional (OTCMKTS:GNMLF) is anticipated to announce its results after the market closes on Wednesday, October 21st. Analysts expect Genomma Lab Internacional to post earnings of $0.0210 per share and revenue of $240.97 million for the quarter.

Genomma Lab Internacional Stock Performance

GNMLF opened at $0.72 on Monday. The business has a fifty day simple moving average of $0.77 and a 200 day simple moving average of $0.89. Genomma Lab Internacional has a 1 year low of $0.69 and a 1 year high of $1.08.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group began coverage on Genomma Lab Internacional in a report on Sunday, July 19th. They set a “hold” rating for the company. One analyst has rated the stock with a Hold rating. According to data from MarketBeat, Genomma Lab Internacional presently has an average rating of “Hold”.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. (OTCMKTS: GNMLF) is a Mexico-based consumer healthcare and personal care company. It develops, markets and distributes over-the-counter medicines, medical devices, cosmetics and hygiene products, primarily through retail pharmacies, supermarkets and other consumer channels.

The company’s portfolio includes products for areas such as pain relief, respiratory health, gastrointestinal care, dermatology, hair care and skin care. Its recognized brands include Asepxia, Cicatricure, Goicoechea, Tío Nacho, Silka and Next, although product availability varies by market.

Genomma Lab was established in Mexico in 1996 and has expanded its operations across Latin America, with a presence that has included markets such as Argentina, Brazil, Chile, Colombia, Ecuador and Peru, as well as the United States.